Medtronic plc (MDT)

Basic

  • Market Cap

    $106.36B

  • EV

    $123.86B

  • Shares Out

    1,329.65M

  • Revenue

    $31.96B

  • Employees

    95,000

Margins

  • Gross

    65.67%

  • EBITDA

    26.55%

  • Operating

    18.88%

  • Pre-Tax

    17.01%

  • Net

    12.84%

  • FCF

    12.66%

Returns (5Yr Avg)

  • ROA

    4.1%

  • ROE

    8.51%

  • ROCE

    7.27%

  • ROIC

    7.33%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $91.06

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $24.02

  • Earnings (Dil)

    $3.08

  • FCF

    $3.04

  • Book Value

    $38.69

Growth (CAGR)

  • Rev 3Yr

    4.67%

  • Rev 5Yr

    1.02%

  • Rev 10Yr

    6.68%

  • Dil EPS 3Yr

    5.68%

  • Dil EPS 5Yr

    14.08%

  • Dil EPS 10Yr

    -1.93%

  • Rev Fwd 2Yr

    3.59%

  • EBITDA Fwd 2Yr

    1.22%

  • EPS Fwd 2Yr

    1.48%

  • EPS LT Growth Est

    4.43%

Dividends

  • Yield

    —

  • Payout

    88.86%

  • DPS

    $2.74

  • DPS Growth 3Yr

    6.95%

  • DPS Growth 5Yr

    7.37%

  • DPS Growth 10Yr

    9.76%

  • DPS Growth Fwd 2Yr

    3.51%

Select a metric from the list below to chart it

Apr '14
Apr '16
Apr '18
Apr '20
Apr '22
LTM
Metric
Apr '14
Apr '15
Apr '16
Apr '17
Apr '18
Apr '19
Apr '20
Apr '21
Apr '22
Apr '23
LTM

Total Revenues

30,557.0

28,913.0

30,117.0

31,686.0

31,227.0

31,958.0

Total Revenues % Chg.

2.0%

-5.4%

4.2%

5.2%

-1.4%

3.7%

Cost of Goods Sold, Total

9,064.0

9,269.0

10,355.0

9,970.0

10,622.0

10,972.0

Gross Profit

21,493.0

19,644.0

19,762.0

21,716.0

20,605.0

20,986.0

Selling General & Admin Expenses, Total

10,273.0

9,882.0

9,956.0

11,720.0

11,801.0

11,884.0

R&D Expenses

2,330.0

2,331.0

2,493.0

2,746.0

2,696.0

2,693.0

Amortization of Goodwill and Intangible Assets

1,764.0

1,756.0

1,783.0

—

—

11.0

Other Operating Expenses

417.0

513.0

40.0

388.0

429.0

363.0

Other Operating Expenses, Total

14,784.0

14,482.0

14,272.0

14,854.0

14,926.0

14,951.0

Operating Income

6,709.0

5,162.0

5,490.0

6,862.0

5,679.0

6,035.0

Interest Expense, Total

-1,444.0

-1,092.0

-925.0

-553.0

-583.0

-683.0

Interest And Investment Income

—

—

—

186.0

386.0

517.0

Net Interest Expenses

-1,444.0

-1,092.0

-925.0

-367.0

-197.0

-166.0

Currency Exchange Gains (Loss)

338.0

477.0

-230.0

198.0

672.0

482.0

Other Non Operating Income (Expenses)

287.0

310.0

340.0

36.0

68.0

18.0

EBT, Excl. Unusual Items

5,890.0

4,857.0

4,675.0

6,729.0

6,222.0

6,369.0

Restructuring Charges

-556.0

-441.0

-617.0

-1,168.0

-645.0

-656.0

Merger & Related Restructuring Charges

—

—

—

-60.0

-134.0

-134.0

Impairment of Goodwill

—

—

—

—

-61.0

—

Gain (Loss) On Sale Of Investments

59.0

-13.0

—

8.0

56.0

-48.0

Gain (Loss) On Sale Of Assets

—

—

—

—

-75.0

-75.0

Asset Writedown

—

-10.0

—

—

—

—

In Process R&D Expenses

-58.0

-25.0

-45.0

—

—

—

Legal Settlements

-166.0

-313.0

-118.0

-95.0

30.0

-75.0

Other Unusual Items

28.0

—

—

103.0

-29.0

55.0

EBT, Incl. Unusual Items

5,197.0

4,055.0

3,895.0

5,517.0

5,364.0

5,436.0

Income Tax Expense

547.0

-751.0

265.0

456.0

1,580.0

1,310.0

Earnings From Continuing Operations

4,650.0

4,806.0

3,630.0

5,061.0

3,784.0

4,126.0

Minority Interest

-19.0

-17.0

-24.0

-22.0

-26.0

-24.0

Net Income

4,631.0

4,789.0

3,606.0

5,039.0

3,758.0

4,102.0

Net Income to Common Incl Extra Items

4,631.0

4,789.0

3,606.0

5,039.0

3,758.0

4,102.0

Net Income to Common Excl. Extra Items

4,631.0

4,789.0

3,606.0

5,039.0

3,758.0

4,102.0

Total Shares Outstanding

1,340.7

1,341.1

1,345.4

1,330.7

1,330.8

1,330.2

Weighted Avg. Shares Outstanding

1,346.4

1,340.7

1,344.9

1,342.4

1,329.8

1,330.3

Weighted Avg. Shares Outstanding Dil

1,357.5

1,351.1

1,354.0

1,351.4

1,332.8

1,332.6

EPS

3.4

3.6

2.7

3.8

2.8

3.1

EPS Diluted

3.4

3.5

2.7

3.7

2.8

3.1

EBITDA

9,368.0

7,825.0

8,192.0

9,569.0

8,123.0

8,484.0